DNDi: Medicine Makers Without Borders
June 30, 2022
The Drugs for Neglected Diseases initiative is doing incredible work – but few realize the true extent of its activities, and their potential to improve health
1 min read

June 30, 2022
The Drugs for Neglected Diseases initiative is doing incredible work – but few realize the true extent of its activities, and their potential to improve health
1 min read
June 30, 2022
For effective and efficient cell and gene therapy manufacture, companies need to make better plasmid design decisions with the end goal in mind: commercialization
3 min read
June 30, 2022
Academia-industry collaboration doesn’t have to be difficult; we just need to appreciate one another’s differences
4 min read
June 29, 2022
Nothing happens in a vacuum – and especially not collaborative, open science
4 min read
June 29, 2022
Single-use technology continues to evolve; single-use bags are now a robust and effective alternative to using bottles in freeze and thaw operations
1 min read
June 29, 2022
DeepMind’s Pushmeet Kohli lays out the connective tissue between DNDi and one of Google’s most futuristic AI assets
4 min read
June 28, 2022
What are the biggest lessons that the pharma industry has learned from the COVID-19 pandemic? Members of The Medicine Maker Power List 2022 provide their views.
8 min read
June 28, 2022
Two friends, two countries; one disease, one network to fight it
6 min read
June 27, 2022
How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2
6 min read
June 22, 2022
Sitting Down With… Akhil Ravi, CEO of Aurigene Pharmaceutical Services, a Dr. Reddy’s Laboratories company, India
6 min read
False
False